In VivoAntigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection
Open Access
- 27 April 2021
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
Abstract
New vaccines are urgently needed against Mycobacterium tuberculosis (Mtb), which kills more than 1.4 million people each year. CD4 T cell differentiation is a key determinant of protective immunity against Mtb, but it is not fully understood how host-pathogen interactions shape individual antigen-specific T cell populations and their protective capacity. Here, we investigated the immunodominant Mtb antigen, MPT70, which is upregulated in response to gamma interferon (IFN-γ) or nutrient/oxygen deprivation of in vitro-infected macrophages. Using a murine aerosol infection model, we compared the in vivo expression kinetics of MPT70 to a constitutively expressed antigen, ESAT-6, and analyzed their corresponding CD4 T cell phenotype and vaccine protection. For wild-type Mtb, we found that in vivo expression of MPT70 was delayed compared to ESAT-6. This delayed expression was associated with induction of less differentiated MPT70-specific CD4 T cells but, compared to ESAT-6, also reduced protection after vaccination. In contrast, infection with an MPT70-overexpressing Mtb strain promoted highly differentiated KLRG1+CX3CR1+ CD4 T cells with limited lung-homing capacity. Importantly, this differentiated phenotype could be prevented by vaccination, and against the overexpressing strain, vaccination with MPT70 conferred protection similar to vaccination with ESAT-6. Together, our data indicate that high in vivo antigen expression drives T cells toward terminal differentiation and that targeted vaccination with adjuvanted protein can counteract this phenomenon by maintaining T cells in a protective less differentiated state. These observations shed new light on host-pathogen interactions and provide guidance on how future Mtb vaccines can be designed to tip the immune balance in favor of the host. IMPORTANCE Tuberculosis, caused by Mtb, constitutes a global health crisis of massive proportions and the impact of the current coronavirus disease 2019 (COVID-19) pandemic is expected to cause a rise in tuberculosis-related deaths. Improved vaccines are therefore needed more than ever, but a lack of knowledge on protective immunity hampers their development. The present study shows that constitutively expressed antigens with high availability drive highly differentiated CD4 T cells with diminished protective capacity, which could be a survival strategy by Mtb to evade T cell immunity against key antigens. We demonstrate that immunization with such antigens can counteract this phenomenon by maintaining antigen-specific T cells in a state of low differentiation. Future vaccine strategies should therefore explore combinations of multiple highly expressed antigens and we suggest that T cell differentiation could be used as a readily measurable parameter to identify these in both preclinical and clinical studies.Keywords
All Related Versions
Funding Information
- Lundbeck Foundation (R249-2017-851)
- Sundhed og Sygdom, Det Frie Forskningsråd (DFF - 7025-00106)
- Gouvernement du Canada | Canadian Institutes of Health Research (FDN-148362)
- HHS | National Institutes of Health (Grant 1R01AI135721)
This publication has 65 references indexed in Scilit:
- T-Cell Immunophenotyping Distinguishes Active From Latent TuberculosisThe Journal of Infectious Diseases, 2013
- Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory SubsetInfection and Immunity, 2012
- Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidateVaccine, 2011
- Role of antigen persistence and dose for CD4+T-cell exhaustion and recoveryProceedings of the National Academy of Sciences, 2010
- Identification ofMycobacterium tuberculosisAntigens of High Serodiagnostic ValueClinical and Vaccine Immunology, 2010
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconservedNature Genetics, 2010
- The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensisClinical and Experimental Immunology, 2009
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological RequirementsPLOS ONE, 2008
- ESAT-6-specific CD4 T cell responses to aerosolMycobacterium tuberculosisinfection are initiated in the mediastinal lymph nodesProceedings of the National Academy of Sciences, 2008
- Expression levels of Mycobacterium tuberculosis antigen‐encoding genes versus production levels of antigen‐specific T cells during stationary level lung infection in miceImmunology, 2006